MedTrace Logo

Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke

NCT00507806 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2007-07-27

No results posted yet for this study

Summary

The study is designed to examine the safety, tolerability, and activity of a combination of microbubbles (perflutren lipid microsphere \[Definity®\]) and continuous monitoring with 2 MHz transcranial Doppler ultrasound (TCD) as an adjunctive therapy to tissue plasminogen activator (tPA) treatment in subjects with acute ischemic stroke.

Conditions

  • Acute Ischemic Stroke

Interventions

DRUG

perflutren lipid microsphere

Sponsors & Collaborators

  • ImaRx Therapeutics

    lead INDUSTRY

Principal Investigators

  • Andrei Alexandrov, MD · The University of Texas Health Science Center, Houston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31
Completion
2006-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00507806 on ClinicalTrials.gov